Abstract | AIMS: METHODS: 101 hypertensive patients with hyperuricemia were detected the genotypes of URAT1 rs1529909 and rs3825016 and undergo a 2-weeks following losartan treatment. Before and after treatment, serum uric acid (SUA) and other clinical data were compared between different genotypes of URAT1 patients. RESULTS: The frequency of rs3825016 (C/T) CT genotype was significant higher in the hypertensive patients with hyperuricemia than that in the healthy controls (32.7 vs 18.8%; p = 0.02). After lorsatan treatment, the patients with the rs3825016 (C/T) or rs1529909 (T/C) mutant genotypes had lower decreased value (DV) of SUA compared with the patients who are wild-type of the variant (p = 0.001 and p < 0.001, respectively). Combined the two variants together, the DV of SUA in two variants both wild-type patients higher than that in the two variants mutant patients (p < 0.0001). CONCLUSION: These results suggest that URAT1 rs3825016 and rs1529909 polymorphisms influence the uricosuric action of losartan. Original submitted 20 August 2014; Revision submitted 15 April 2015.
|
Authors | Hong Sun, Qiang Qu, Jian Qu, Xiao-Ya Lou, Yan Peng, Ying Zeng, Guo Wang |
Journal | Pharmacogenomics
(Pharmacogenomics)
Vol. 16
Issue 8
Pg. 855-63
(Jul 2015)
ISSN: 1744-8042 [Electronic] England |
PMID | 26086348
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Organic Anion Transporters
- Organic Cation Transport Proteins
- SLC22A12 protein, human
- Uricosuric Agents
- Losartan
|
Topics |
- Aged
- Female
- Genetic Association Studies
- Genotype
- Humans
- Hypertension
(complications, drug therapy, genetics)
- Hyperuricemia
(complications, drug therapy, genetics)
- Losartan
(administration & dosage, adverse effects)
- Male
- Middle Aged
- Organic Anion Transporters
(genetics)
- Organic Cation Transport Proteins
(genetics)
- Polymorphism, Single Nucleotide
- Uricosuric Agents
(administration & dosage, adverse effects)
|